MIDHAT SYED: Open Payments
NPI 1437631512 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 22 payments from 12 companies in 2025. Trend: 2023 $1,075 · 2024 $682 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 4 | $90 |
| Solventum Corporation | 3 | $81 |
| Kerecis Limited | 3 | $62 |
| Paratek Pharmaceuticals, Inc. | 2 | $56 |
| Urgo Medical North America, LLC | 3 | $55 |
| Integra LifeSciences Corporation | 1 | $43 |
| RedDress USA, Inc. | 1 | $36 |
| MIMEDX Group, Inc. | 1 | $34 |
| Tactile Systems Technology Inc | 1 | $26 |
| Boston Scientific Corporation | 1 | $22 |
Products named: Kerecis SurgiClose, NUZYRA, RENASYS TOUCH, TCC-EZ, SNAP, URGOK2, COLLAGENASE SANTYL, ActiGraft.
Industry payments across TX — which companies pay providers there.
